AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net buying: insiders sold $0 and bought $1.4M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$1.4M netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 9 added, 2 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $391.00
- 52-wk high
- $434.35
- High
- $395.44
- 52-wk low
- $270.87
- Low
- $390.00
- Prev close
- $394.59
- Mkt cap
- $85.17B
- P/E
- 17.4x
- Volume
- 884.5K
- Fwd P/E
- 13.7x
- Beta
- 0.70
- Div yield
- 1.74%
- P/S
- 0.4x
- P/B
- 1.9x
- Profit margin
- +2.5%
- Op margin
- +4.6%
- ROE
- +11.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ELV filings
Are insiders buying or selling Elevance Health Inc (ELV) stock?
Net buying: insiders sold $0 and bought $1.4M of ELV stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Boudreaux, Gail (President and CEO), who bought $1M. The latest filing was on Jul 17, 2026.
Which members of Congress have traded ELV recently?
None. No member of Congress disclosed a ELV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ELV smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- QR
Qube Research
$214.6M
added
Sells/Trims (2)
- BA
Balyasny
$73.9M
trimmed
- DS
D.E. Shaw
$64.6M
trimmed
What insiders are doing
Buys (2)
- BG
Boudreaux Gail
$1.0M
bought
- PR
Peru Ramiro G
$366K
bought
Sells (1)
- PR
Penczek Ronald W
$149K
sold
How top traders are positioned
No tracked top-trader positions in ELV right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 20.6% above what analysts expected.
Earnings per share
$6.18 expected
Revenue
No comparable estimate
Reports Oct 20, 2026, in 19 days
Estimates as of Sep 30, 2026
EPS expected
$4.55 to $4.99
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $50.71B | $49.75B | $50.18B | $50.47B |
| Cost of what it sold | $38.14B | $38.06B | $41.08B | $5.49B |
| Gross profit | $12.57B | $11.68B | $9.10B | $44.98B |
| What it spent | ||||
| Sales and admin | — | — | $6.33B | — |
| Other operating costs | $10.81B | $11.10B | $112.0M | $42.92B |
| Total operating expenses | $10.81B | $11.10B | $6.44B | $42.92B |
| What was left | ||||
| Operating profit | $1.76B | $581.0M | $2.66B | $2.06B |
| Interest on debt | $351.0M | $366.0M | $357.0M | $56.0M |
| Profit before tax | $1.41B | $215.0M | $2.30B | $1.94B |
| Tax | $219.0M | -$331.0M | $544.0M | $483.0M |
| Net profit | $1.19B | $547.0M | $1.76B | $1.46B |
| EBITDA | $2.14B | $987.0M | $2.77B | $2.10B |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
New analysis points finger at payers for IDR problems
NeutralSep 25Elevance Health stock heads into the open after a 0.8 percent gain
Leans bullishSep 25Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance
NeutralSep 24Five Texas Hospitals Tied to HCA Sue Independence Blue Cross Over $345,000 in Denied Claims, Including Emergency Care
NeutralSep 24Elevance Health stock carries a USD 27 adjusted EPS outlook
BullishSep 24AM Best withdraws ratings of Elevance Health's Hawaii captive
NeutralSep 24Elevance Health stock heads into the open after a 0.45 percent drop
Leans bearishSep 24Did UnitedHealth Name The Fix Before Its Stock Ran?
Leans bullishSep 23